Catalyst Wire Dossier Catalyst Wire Dossier

GS010

lenadogene nolparvovec · GenSight Biologics
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for GS010, covering 2020-01-23 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy & Safety Study of Bilateral IVT Injection of GS010 in LHON Subjects Due to the ND4 Mutation for up to 1 Year [Phase 3]

See pricing